Biotech IPO gains crush AI listings with standout 55% return
· financialpost.com
Drivers of biotech and pharma’s outperformance include a 13 per cent gain in the Nasdaq Biotechnology index this year. Find out more here.
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Thanks for signing up!
A welcome email is on its way. If you don't see i...